Plain-English translation of NCT07140575 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS) as a treatment for young people whose depression hasn't responded to standard treatments like therapy or antidepressant medications. Instead of coming to a clinic five days a week for weeks, you'd receive the treatment twice daily while staying in the hospital, where you'd also continue your schooling and other support. The magnetic stimulation is designed to help improve mood by gently activating a specific area of your brain.
One in three young people with depression don't get better with medication or therapy alone, and existing rTMS treatment requires frequent clinic visits that are hard to fit into school and family life. This study is exploring whether providing this treatment in a hospital setting with twice-daily sessions could make it faster, easier to access, and better suited to young people's needs.
You likely qualify if…
You likely don't qualify if…
You would be admitted to the hospital for a stay lasting several weeks. During your stay, you would receive the magnetic brain stimulation treatment twice each day (rather than once daily at a clinic). Between treatments, you would participate in regular schooling on the hospital unit and receive other therapeutic support from the care team. The study is designed to understand whether this faster, hospital-based approach is practical and works well for young people like you.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Canada